In this webinar we will give an introduction to the innovation funding for interventions in the German Hospital care and the link the government sponsored clinical trial.
Historically Germany has been a market with easy access for medical devices used in hospitals through the NUB-innovation funding scheme. Since the introduction of the new 137(h) legislation a few years ago, this has changed.
The new legislation will for many innovations lead to a government sponsored clinical trial, where the surgical procedure is covered from the payer and the company pays a portion of the overhead cost for trial.
At first this may look like a barrier that excludes the German market in the early European strategy. Bearing in mind that all European countries will require high-level evidence at some stage, this may be the least expensive / burdensome way to establish the required evidence. If you have been able to establish such trial, your investors and potential buyers knows that a successful outcome in the trial is very likely to lead to reimbursement and open up one of the largest markets in Europe.
The webinar will be shared by Dr Martin Braun who will explain the system for innovation funding and Mattias Kyhlstedt who will cover the new legislation and the government sponsored clinical trial.
Dr Martin Braun is a physician and expert for the health care system. His specialty is the health policy strategy for the reimbursement of hospital services.
He studied Medicine at the University of Heidelberg. He worked as a clinician in a hospital for 10 years and specialised in Internal Medicine, Gastroenterology and Diabetology. In the course of his postgraduate studies at the University of Heidelberg/Mannheim, he received a master’s degree in Health Care Management. Furthermore, he completed additional training in Quality Management in accordance with the requirements of the German Medical Association. Until 2000, he worked as a Consultant in the Ansbach Clinical Centre. In 2001, he moved to the German Hospital Federation in Düsseldorf, where he was the Assistant Head of the Medical Department. From 2003 to 2010, he was the Head of the Medical Department of the German DRG Institute (InEK GmbH) in Siegburg, where he was responsible for the development of the German DRG System. He, simultaneously, supervised the international collaboration, for example, with Switzerland and Cyprus. At the same time, he taught at several Colleges, e.g. Health Care Management Faculty at the University of Applied Sciences in Krefeld.
In January 2011, he founded a consulting company. He has been working as a Health Care Management Expert at a national and international level since that time. He advised a couple of countries, e.g. Thailand, Slovakia, Malta, Turkey and Serbia with respect to the financing of hospital services with the assistance of DRGs. Since 2012, he is consulting the Greek Ministry of Health on the introduction of a DRG System in Greece.